CHARACTERIZATION OF CLONED HUMAN CHOLECYSTOKININ-B RECEPTOR AS A GASTRIN RECEPTOR

被引:0
|
作者
MIYAKE, A
MOCHIZUKI, S
KAWASHIMA, H
机构
关键词
CLONED CCK-B RECEPTOR; CHOLECYSTOKININ; GASTRIN; YM022;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cholecystokinin (CCK)-B receptor cloned from human brain was characterized as a gastrin receptor by using heterologous expression systems of COS-7 cells and Xenopus oocytes. I-125-gastrin binding to human CCK-B receptor expressed in COS-7 was time-dependent, saturable and also specific, as well as (125)-I-CCK-8. The binding of I-125-gastrin was inhibited by CCK-8 about 10-fold more potently than by gastrin. The rank order of potency of several antagonists to I-125-gastrin binding was YM022 > CI-988 > L-365,260 > L-364,718. Addition of GTP gamma S, a nonhydrolysable analog of GTP, dose-dependently inhibited I-125-gastrin binding, and lowered the gastrin binding affinity, Gastrin (10(-9)-10(-7) M) also evoked a Ca2+-dependent Cl- current in Xenopus oocytes expressing CCK-B receptors. These results suggest that the pharmacological profile of the cloned human CCK-B receptor using I-125-gastrin is closely parallel to that reported in gastric mucosa, and that the receptor transduces cellular signals of gastrin as well as those of CCK-8.
引用
收藏
页码:1339 / 1343
页数:5
相关论文
共 50 条
  • [21] QUINAZOLINONE CHOLECYSTOKININ-B RECEPTOR LIGANDS
    YU, MJ
    THRASHER, KJ
    MCCOWAN, JR
    MASON, NR
    MENDELSOHN, LG
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (04) : 1505 - 1508
  • [22] Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth
    Hellmich, MR
    Rui, XL
    Hellmich, HL
    Fleming, RYD
    Evers, BM
    Townsend, CM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) : 32122 - 32128
  • [23] BIOLOGICAL FUNCTION OF THE HUMAN CHOLECYSTOKININ-B GASTRIN RECEPTOR AND ITS SIGNALING PATHWAY INVOLVING TYROSINE KINASES
    MATSUI, T
    TANIGUCHI, T
    MURAYAMA, T
    IWATA, N
    ITO, M
    CHIHARA, K
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 22 - 22
  • [24] Gastrin selectivity for the cholecystokinin-B/gastrin receptor is determined by tertiary receptor structure rather than by subtype specific domains.
    Ren, Y
    Elkeeb, D
    Sundararajan, L
    Schmitz, F
    Wu, MJ
    Beinborn, M
    Kopin, AS
    GASTROENTEROLOGY, 2000, 118 (04) : A308 - A308
  • [25] Reversibility of cholecystokinin-B/gastrin receptor blockade:: A study of the gastrin-ECL cell axis in the rat
    Norlén, P
    Lindström, E
    Ding, XQ
    Kitano, M
    Håkanson, R
    PHARMACOLOGY & TOXICOLOGY, 1999, 84 (04): : 159 - 164
  • [26] Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy
    Kopin, AS
    McBride, EW
    Gordon, MC
    Quinn, SM
    Beinborn, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 11043 - 11048
  • [27] Cloning and characterization of 5′-end alternatively spliced human cholecystokinin-B receptor mRNAs
    Monstein, HJ
    Nilsson, I
    Ellnebo-Svedlund, K
    Svensson, SPS
    RECEPTORS & CHANNELS, 1998, 6 (03): : 165 - 177
  • [28] Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells
    Ding, XQ
    Lindstrom, E
    Hakanson, R
    PHARMACOLOGY & TOXICOLOGY, 1997, 81 (01): : 19 - 25
  • [29] Cholecystokinin-B/gastrin receptor scintigraphy for the staging of metastatic medullary thyroid cancer (MTC).
    Behr, TM
    Behe, M
    Gratz, S
    Hüfner, M
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 98P - 98P
  • [30] Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022
    Murayama, T
    Matsumori, Y
    Iwata, N
    Ito, M
    Taniguchi, T
    Chihara, K
    Matsui, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (07): : 743 - 750